{"url":"https://lda.senate.gov/api/v1/filings/3a0cdcdf-d2bd-4ae0-81d7-e9ecf19bec96/","filing_uuid":"3a0cdcdf-d2bd-4ae0-81d7-e9ecf19bec96","filing_type":"4T","filing_type_display":"4th Quarter - Termination","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/3a0cdcdf-d2bd-4ae0-81d7-e9ecf19bec96/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jeff Ricchetti","dt_posted":"2023-01-18T14:03:10-05:00","termination_date":"2022-12-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"Suite 1150 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":62778,"url":"https://lda.senate.gov/api/v1/registrants/62778/","house_registrant_id":35395,"name":"RICCHETTI INCORPORATED","description":"Lobbying and consulting","address_1":"601 13th Street, NW","address_2":"Suite 830N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JEFF RICCHETTI","contact_telephone":"+1 202-879-9382","dt_updated":"2026-07-13T18:17:38.137744-04:00"},"client":{"id":207749,"url":"https://lda.senate.gov/api/v1/clients/207749/","client_id":1004874,"name":"VAXART INC.","general_description":"Vaccine development","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-11-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Legislative and regulatory policies regarding oral vaccine development and funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":30648,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"RICCHETTI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}